B cell isolation with MARS® Platform
Immunotherapy requires purified cells for a variety of experimental needs. For patients with protein deficiencies for whom gene therapy is not an option, B cells provide an excellent factory for producing immunoglobulin in lymphocytes or plasma cells. Obtaining a large number of B cells requires a cell isolation solution for both pre-clinical testing on a […]
